China’s NMPA Grants Conditional Approval for Taletrectinib Adipate Capsules

📩 info@dengyuemed.com
🔗https://dengyuemed.com

#ChinaNMPA #DrugApproval #TaletrectinibAdipate #Dabole #ROS1Positive #NSCLC #LungCancer #TargetedTherapy #Oncology #BaoyuanBiopharma